Rolimus 10 mg Tablet

Product Description

Rolimus 10 mg tablet is a targeted anticancer therapy designed to combat a range of advanced malignancies, including those affecting the pancreas, stomach, intestines, and lungs, particularly when surgical options are no longer viable. This medication is also specifically indicated for postmenopausal women battling advanced hormone receptor-positive and HER2-negative breast cancer. Additionally, Rolimus is effective for adults with advanced kidney cancer who have not responded to previous treatments such as sunitinib or sorafenib. The active ingredient, everolimus, works by inhibiting a crucial protein that cancer cells rely on for growth and division, thereby slowing down the progression of the disease. Patients should be aware of potential side effects, including increased risk of infections and changes in blood cell counts, necessitating regular monitoring during treatment. It's important to discuss any existing health conditions or concurrent medications with a healthcare provider before starting Rolimus to ensure safe and effective use. This medication represents a vital option in the oncological arsenal, aiming to improve outcomes for patients facing challenging cancer diagnoses.